Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Impact of Mental Health and Substance Use Disorders on Emergency Department Visit Outcomes for HIV Patients.

Choi BY, DiNitto DM, Marti CN, Choi NG.

West J Emerg Med. 2016 Mar;17(2):153-64. doi: 10.5811/westjem.2016.1.28310. Epub 2016 Mar 2.

2.

Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E.

Curr HIV Res. 2015;13(1):43-54. Review.

3.

Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.

Eduardo E, Lamb MR, Kandula S, Howard A, Mugisha V, Kimanga D, Kilama B, El-Sadr W, Elul B.

PLoS One. 2014 Jul 30;9(7):e103864. doi: 10.1371/journal.pone.0103864. eCollection 2014.

4.

PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice.

Huang W, Chen L, Zhang B, Park M, Toborek M.

J Cereb Blood Flow Metab. 2014 Apr;34(4):646-53. doi: 10.1038/jcbfm.2013.240. Epub 2014 Jan 15.

5.

Poor Aerobic Fitness May Contribute to Cognitive Decline in HIV-infected Older Adults.

Mapstone M, Hilton TN, Yang H, Guido JJ, Luque AE, Hall WJ, Dewhurst S, Shah K.

Aging Dis. 2013 Aug 27;4(6):311-9. doi: 10.14336/AD.2013.0400311. eCollection 2013.

6.
7.

Synergistic effects of HIV infection and older age on daily functioning.

Morgan EE, Iudicello JE, Weber E, Duarte NA, Riggs PK, Delano-Wood L, Ellis R, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):341-8. doi: 10.1097/QAI.0b013e31826bfc53.

8.

Neuropsychiatric complications of aging with HIV.

Watkins CC, Treisman GJ.

J Neurovirol. 2012 Aug;18(4):277-90. doi: 10.1007/s13365-012-0108-z. Epub 2012 May 30. Review.

9.

Autophagy in dementias.

Kragh CL, Ubhi K, Wyss-Coray T, Masliah E.

Brain Pathol. 2012 Jan;22(1):99-109. doi: 10.1111/j.1750-3639.2011.00545.x. Review. Erratum in: Brain Pathol. 2012 Mar;22(2):259. Wyss-Corey, Tony [corrected to Wyss-Coray, Tony].

10.

Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.

Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR.

Brain Res. 2011 Jul 5;1399:96-115. doi: 10.1016/j.brainres.2011.05.015. Epub 2011 May 14. Review.

11.

Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults.

Morgan EE, Woods SP, Delano-Wood L, Bondi MW, Grant I; HIV Neurobehavioral Research Program (HNRP) Group.

Neuropsychology. 2011 Sep;25(5):645-54. doi: 10.1037/a0023792.

12.

Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis.

Wilk A, Urbanska K, Yang S, Wang JY, Amini S, Del Valle L, Peruzzi F, Meggs L, Reiss K.

J Neurosci Res. 2011 Feb;89(2):183-98. doi: 10.1002/jnr.22542. Epub 2010 Dec 8.

13.

The Effects of Age and HIV on Neuropsychological Performance.

Valcour V, Paul R, Neuhaus J, Shikuma C.

J Int Neuropsychol Soc. 2011 Jan;17(1):190-5. doi: 10.1017/S1355617710001438. Epub 2010 Dec 10.

14.

Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis.

Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I; HIV Neurobehavioral Research Center (HNRC) Group.

AIDS Behav. 2011 Aug;15(6):1187-96. doi: 10.1007/s10461-010-9815-8.

15.

Medication and finance management among HIV-infected adults: the impact of age and cognition.

Thames AD, Kim MS, Becker BW, Foley JM, Hines LJ, Singer EJ, Heaton RK, Castellon SA, Hinkin CH.

J Clin Exp Neuropsychol. 2011 Feb;33(2):200-9. doi: 10.1080/13803395.2010.499357. Epub 2010 Aug 6.

16.

Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Durvasula RS, Hinkin CH.

Am J Infect Dis. 2006;2(2):67-73.

17.

Loneliness and HIV-related stigma explain depression among older HIV-positive adults.

Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE.

AIDS Care. 2010 May;22(5):630-9. doi: 10.1080/09540120903280901.

18.

Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.

Nowacek AS, McMillan J, Miller R, Anderson A, Rabinow B, Gendelman HE.

J Neuroimmune Pharmacol. 2010 Dec;5(4):592-601. doi: 10.1007/s11481-010-9198-7. Epub 2010 Mar 17.

19.

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Kabanov AV, Gendelman HE.

Prog Polym Sci. 2007;32(8-9):1054-1082.

20.

NanoART, neuroAIDS and CNS drug delivery.

Nowacek A, Gendelman HE.

Nanomedicine (Lond). 2009 Jul;4(5):557-74. doi: 10.2217/nnm.09.38. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk